Hypoxia-induced fatty acid transporter translocation increases fatty acid transport and contributes to lipid accumulation in the heart

FEBS Letters

Volumn 580, Issue 15, 2006, Pages 3617-3623

  Chabowski, Adrian ^a,d   Górski, Jan ^a   Calles Escandon, Jorge ^b   Tandon, Narendra N ^c   Bonen, Arend ^d  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cardiac myocytes; FABPpm; FAT CD36; Hypoxia; Lipids

Indexed keywords

ADENYLATE KINASE; CD36 ANTIGEN; FATTY ACID; FATTY ACID BINDING PROTEIN; LIPID; LONG CHAIN FATTY ACID; PALMITIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART; HEART MUSCLE; HEART MUSCLE CELL; HYPOXIA; ISOLATED HEART; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANOXIA; BIOLOGICAL TRANSPORT; FATTY ACID TRANSPORT PROTEINS; FATTY ACIDS; LIPID METABOLISM; MALE; MULTIENZYME COMPLEXES; MYOCARDIUM; PALMITATES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 33745151032     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.05.045     Document Type: Article

References (54)

1. van der Vusse G.J., Glatz J.F., Stam H.C., and Reneman R.S. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol. Rev. 72 (1992) 881-940
2. Luiken J.J.F.P., Arumugam Y., Dyck D.J., Bell R.C., Pelsers M.L., Turcotte L.P., Tandon N.N., Glatz J.F.C., and Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 276 (2001) 40567-40573
3. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., Noon G.P., Frazier O.H., and Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 18 14 (2004) 1692-1700
4. Young M.E., Guthrie P.H., Razeghi P., Leighton B., Abbasi S., Patil S., Youker K.A., and Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 51 (2002) 2587-2595
5. Corr P.B., Gross R.W., and Sobel B.E. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ. Res. 55 (1984) 135-154
6. Hamilton J.A., and Kamp F. How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids?. Diabetes 48 (1999) 2255-2269
7. Hamilton J., Guo W., and Kamp F. Mechanisms of cellular uptake of long-chain fatty acids: Do we need cellular proteins?. Mol. Cell Biochem. 239 (2002) 17-23
8. Bonen A., Glatz J.F., and Luiken J.J.F.P. Regulation of fatty acid transport and membrane transporters in health and disease. Mol. Cell Biochem. 239 (2002) 181-192
9. Schaffer J.E. Fatty acid transport: the roads taken. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E239-E246
10. Coburn C.T., Knapp Jr. F., Febbraio M.A., Beets L., Silverstein L., and Abumrad N.A. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissue of CD36 knockout mice. J. Biol. Chem. 275 (2000) 32523-32529
11. Bonen A., Luiken J.J.F.P., Arumugam Y., Glatz J.F.C., and Tandon N.N. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 275 (2000) 14501-14508
12. Koonen D.P., Glatz J.F., Bonen A., and Luiken J.J. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim. Biophys. Acta 1736 3 (2005) 163-180
13. Chabowski A., Coort S.L., Calles-Escandon J., Tandon N.N., Glatz J.F., Luiken J.J., and Bonen A. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am. J. Physiol. Endocrinol. Metab. 287 4 (2004) E781-E789
14. Luiken J.J.F.P., Koonen D.P.Y., Willems J., Zorzano A., Fischer Y., van der Vusse G.J., Bonen A., and Glatz J.F.C. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51 (2002) 3113-3119
15. Luiken J.J.F.P., Coort S.M.L., Willems J., Coumans W.A., Bonen A., van der Vusse G.J., and Glatz J.F.C. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52 (2003) 1627-1634
16. Chabowski A., Coort S.L., Calles-Escandon J., Tandon N.N., Glatz J.F., Luiken J.J., and Bonen A. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett. 579 11 (2005) 2428-2432
17. Scheuer J., and Brachfeld N. Myocardial uptake and fractional distribution of palmitate-1 C14 by the ischemic dog heart. Metabolism 15 (1966) 945-954
18. van der Vusse G.J., Roemen T.H., Prinzen F.W., Coumans W.A., and Reneman R.S. Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. Circ. Res. 50 4 (1982) 538-546
19. Moore K.H., Radloff J.F., Hull F.E., and Sweeley C.C. Incomplete fatty acid oxidation by ischemic heart: beta-hydroxy fatty acid production. Am. J. Physiol. Heart Circ. Physiol. 239 (1980) H257-H265
20. Shearer J., Fueger P.T., Rottman J.N., Bracy D.P., Martin P.H., and Wasserman D.H. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. Am. J. Physiol. Endocrinol. Metab. 287 5 (2004) E871-E877
21. Kudo N., Barr A.J., Barr R.L., Desai S., and Lopaschuk G.D. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270 29 (1995) 17513-17520
22. Saddik M., Gamble J., Witters L.A., and Lopaschuk G.D. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J. Biol. Chem. 268 (1993) 25836-25845
23. Moore F., Weekes J., and Hardie D.G. Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion. Eur. J. Biochem. 199 3 (1991) 691-697
24. Frederich M., Zhang L., and Balschi J.A. Hypoxia and AMP independently regulate AMP activated protein kinase activity in heart. Am. J. Physiol. Heart Circ. Physiol. 288 5 (2005) H2412-H2421
25. Matsuno K., Diaz-Ricard M., Montgomery R.R., Aster T., Jamieson G.A., and Tandon N.N. Inhibition of platelet adhesion to collagen by monoclonal anti CD36 antibodies. Br. J. Haematol. 92 (1996) 960-967
26. Calles-Escandon J., Sweet L., Ljungqvist O., and Hirshman M.F. The membrane associated 40 kDa fatty acid binding protein is present in human skeletal muscle. Life Sci. 58 (1996) 19-28
27. Van der Vusse G.J., Roemen T.H.M., and Reneman R.S. Assessment of fatty acids in dog left ventricular myocardium. Biochim. Biophys. Acta 617 (1980) 347-352
28. Chabowski A., Baranczuk E., and Gorski J. Effect of adrenalin, insulin and contractions on the content of the free fatty acid fraction in skeletal muscle. J. Physiol. Pharmacol. 56 3 (2005) 381-390
29. Saddik M., and Lopaschuk G.D. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J. Biol. Chem. 266 13 (1991) 8162-8170
30. Carroll N.V., Longley R.W., and Roe J.H. The determination of glycogen in liver and muscle by use of anthrone reagent. J. Biol. Chem. 220 2 (1956) 583-593
31. Fisher Y., Rose H., and Kammermeier H. Highly insulin responsive isolated rat heart muscle cells yield by a modified isolation method. Life Sci. 49 (1991) 1679-1688
32. Fuller W., Eaton P., Medina R.A., Bell J., and Shattock M.J. Differential centrifugation separates cardiac sarcolemmal and endosomal membranes from Langendorff-perfused rat hearts. Anal. Biochem. 293 (2001) 216-223
33. Chabowski, A., Momken, I., Coort, S.L.M., Calles-Escandon, J., Tandon, N.N., Glatz, J.F.C., Luiken, J.J.F.P. and Bonen, A. A prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol. Cell Biochem. (in press), doi:10.1007/s11010-006-9140-8.
34. Li J., Miller E.J., Ninomiya-Tsuji J., Russell III R.R., and Young L.H. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ. Res. 97 9 (2005) 872-879
35. Carvalheira J.B., Calegari V.C., Zecchin H.G., Nadruz Jr. W., Guimaraes R.B., Ribeiro E.B., Franchini K.G., Velloso L.A., and Saad M.J. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance. Endocrinology 144 12 (2003) 5604-5614
36. Sundgren N.C., Giraud G.D., Schultz J.M., Lasarev M.R., Stork P.J., and Thornburg K.L. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am. J. Physiol. 285 6 (2003) R1481-R1489
37. Mehrhof F.B., Muller F.U., Bergmann M.W., Li P., Wang Y., Schmitz W., Dietz R., and von Harsdorf R. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase dependent activation of the transcription factor cAMP response element-binding protein. Circulation 104 17 (2001) 2088-2094
38. Tripp M.E. Developmental cardiac metabolism in health and disease. Pediatr. Cardiol. 10 3 (1989) 150-158
39. Stanley W.C., Recchia F.A., and Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85 3 (2005) 1093-1129
40. Lopaschuk G.D., Belke D.D., Gamble J., Itoi T., and Schonekess B.O. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim. Biophys. Acta 1213 3 (1994) 263-276
41. Rabitzsch G., Mair J., Lechleitner P., Noll F., Hofmann U., Krause E.G., Dienstl F., and Puschendorf B. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin. Chem. 41 (1995) 966-978
42. Gloster J., and Harris P. Effect of anaerobiosis on the incorporation of (14C) acetate into lipid in the perfused rat heart. J. Mol. Cell Cardiol. 4 3 (1972) 213-228
43. Tatsumi T., Shiraishi J., Keira N., Akashi K., Mano A., Yamanaka S., Matoba S., Fushiki S., Fliss H., and Nakagawa M. Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res. 59 2 (2003) 428-440
44. Saddik M., and Lopaschuk G.D. Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J. Biol. Chem. 267 6 (1992) 3825-3831
45. Hutter J.F., and Soboll S. Role of fatty acid metabolites in the development of myocardial ischemic damage. Int. J. Biochem. 24 3 (1992) 399-403
46. Burton K.P., Buja L.M., Sen A., Willerson J.T., and Chien K.R. Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Correlation with the loss of contractile function and the development of calcium overload. Am. J. Pathol. 124 2 (1986) 238-245
47. Lopaschuk G.D., and Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ. Res. 65 2 (1989) 378-387
48. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., and Unger R.H. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. USA 97 4 (2000) 1784-1789
49. Fogli S., Nieri P., and Breschi M.C. The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J. 8 6 (2004) 664-675
50. Beresewicz A., Dobrzyn A., and Gorski J. Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning. J. Physiol. Pharmacol. 53 3 (2002) 371-382
51. Zhang D.X., Fryer R.M., Hsu A.K., Zou A.P., Gross G.J., Campbell W.B., and Li P.L. Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res. Cardiol. 96 3 (2001) 267-274
52. Mu J., Brozinick Jr. J.T., Valladares O., Bucan M., and Birnbaum M.J. A role for AMP activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7 5 (2001) 1085-1094
53. Steinberg G.R., Dyck D.J., Calles-Escandon J., Tandon N.N., Luiken J.J.F.P., Glatz J.F., and Bonen A. Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J. Biol. Chem. 277 (2002) 8854-8860
54. Palanivel R., and Sweeney G. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett. 579 (2005) 5049-5054